We addressed VGF peptide changes in fibroblast cell cultures and in plasma obtained from ALS patients, in parallel with spinal cord and plasma samples from the G93A-SOD1 mouse model. The gene discussed is VGF; the disease is amyotrophic lateral sclerosis.